The Patent Finder

Alfasigma S.P.A.

82 patents currently held · Updated Nov 20, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
26
Ending by 2030
Nov 2026
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Nov 28, 2026
    The maintenance fee for Homogeneous formulation comprising omega-3 polyunsatured fatty acid and resveratrol for oral administration (US 10,300,035) comes due Nov 28, 2026. Unpaid by May 28, 2027, it lapses early.
  • 1 fee due Jan 21, 2027
    The maintenance fee for Composition useful for the prevention or reduction of the progression of prostate cancer (US 9,084,812) comes due Jan 21, 2027. Unpaid by Jul 21, 2027, it lapses early.
  • 1 fee due Feb 13, 2027
    The maintenance fee for Methods for the Treatment of Cardiovascular Disorders (US 10,376,520) comes due Feb 13, 2027. Unpaid by Aug 13, 2027, it lapses early.
  • 3 fees due Mar 8 to 12, 2027 · next Mar 8
  • 2 fees due Apr 1 to 6, 2027 · next Apr 1
  • 2 fees due Jun 3 to 12, 2027 · next Jun 3
  • 2 fees due Jul 14 to 19, 2027 · next Jul 14
  • 2 fees due Aug 11 to 13, 2027 · next Aug 11
  • 1 fee due Sep 15, 2027
    The maintenance fee for Aminotriazolopyridine for Use in the Treatment of Inflammation, and Pharmaceutical Compositions Thereof (US 9,284,311) comes due Sep 15, 2027. Unpaid by Mar 15, 2028, it lapses early.
  • 1 fee due Oct 12, 2027
    The maintenance fee for Novel Compound Useful for the Treatment of Degenerative and Inflammatory Diseases (US 9,309,244) comes due Oct 12, 2027. Unpaid by Apr 12, 2028, it lapses early.
  • 1 fee due Nov 7, 2027
    The maintenance fee for Pharmaceutical Compositions Comprising a Jak Inhibitor (US 11,975,008) comes due Nov 7, 2027. Unpaid by May 8, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 2 terms have ended since Aug 22, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,842,023Container for vial of radiopharmaceutical and set for its infusion in a patient or for its transfer elsewhere
In force
 · USPTO record
In forceUSPTO record
US RE45,968Vector for efficient selection and/or maturation of an antibody and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 7,560,485Method for treating intermittent claudication comprising the administration of propionyl L-carnitine and a concomitant physical training
In force
 · USPTO record
In forceUSPTO record
US 8,658,671Crystalline form of a quinolinone-carboxamide compound
In force
 · USPTO record
In forceUSPTO record
US 10,280,177Use of polyols to obtain stable polymorphous forms of rifaximin
In force
 · USPTO record
In forceUSPTO record
US 8,193,196Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations
In force
 · USPTO record
In forceUSPTO record
US RE48,286Steroids as agonists for FXR
In force
 · USPTO record
In forceUSPTO record
US 8,217,054Use of polyols to obtain stable polymorphous forms of rifaximin
In force
 · USPTO record
In forceUSPTO record
US 7,728,004Crystalline Form of a Quinolinone-Carboxamide Compound
In force
 · High confidence
In forceHigh confidence
US 8,765,778Rifamycin derivatives
In force
 · USPTO record
In forceUSPTO record
10 of 82 patents shown.
Pro members see all 82.
Pro members: see all 82 patents
Also on record, not counted in the 82: 25 lapsed for an unpaid fee · 55 ended at full term · 1 surrendered on reissue. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

5 pending · 9 abandoned · 9 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited